This functionality is implemented using Javascript. It cannot work without it, etc...

Medication-related Osteonecrosis of the jaws (MRONJ) for the Practicing Dentist


SKU: N/A Categories: ,



Osteonecrosis of the jaws (ONJ) is a devastating complication of antiresorptive medications utilized for benign and malignant disorders of bone metabolism. ONJ is defined as exposed, necrotic bone in the maxillofacial region that has persisted for more than eight weeks in a patient with current or previous bisphosphonate treatment, without a history of radiation therapy to the jaws. ONJ was first identified in 2003 and 2004, and its prevalence is reported between 0.8-12%. Difficulties with diagnosis, prevention and treatment exist, often making dentists uncomfortable recognizing and treating patients on these medications. This lecture will discuss ONJ risk, diagnosis, prevention, and management. Specific case discussions will also be included.

About the speaker:

Dr. Aghaloo is a Professor in Oral and Maxillofacial Surgery at the UCLA School of Dentistry. She is a diplomate of the American Board of Oral and Maxillofacial Surgery. Her clinical practice focuses on bone and soft tissue regeneration and dental implants.



Location: The DoubleTree by Hilton Hotel

6161 W. Centinela Ave, Culver City, CA 90230

Date/Time: Tuesday, March 19, 2019 6:00 p.m. to 9:30 p.m.

Fee: $50.00 Members  – $60.00 Non- Member Dentist – $50.00 Staff

CEU’s: 2

Additional information

Registration Types

Guest, Non-Member Dentist, RDH/DA/Staff, Student, WLADS Member